Health
Drug-Resistant ‘Nightmare Bacteria’ Infections Surge Across US, CDC Warns
Drug-resistant infections linked to so-called “nightmare bacteria” are rising sharply in the United States, with rates climbing nearly 70 percent between 2019 and 2023, according to new data from the Centers for Disease Control and Prevention (CDC).
The surge is being driven by bacteria carrying the NDM gene, which renders many treatments ineffective. Once considered rare and primarily associated with patients who had received medical care abroad, these infections are now spreading more widely across the US. CDC researchers published their findings Monday in the Annals of Internal Medicine.
The study found that cases of carbapenem-resistant bacterial infections — resistant even to last-resort antibiotics — rose from fewer than 2 per 100,000 people in 2019 to more than 3 per 100,000 in 2023, a 69 percent increase. But infections specifically caused by NDM-producing bacteria surged more than fivefold over the same period, from 0.25 to about 1.35 cases per 100,000.
“The rise of NDMs in the US is a grave danger and very worrisome,” said David Weiss, an infectious disease researcher at Emory University. He warned that many people may be carrying the bacteria unknowingly, raising the risk of community spread.
The threat extends to common illnesses long considered easy to treat. “Infections like urinary tract infections could become chronic problems,” said Dr. Maroya Walters, one of the study’s authors.
Currently, only two antibiotics are effective against NDM-linked infections, and both are costly treatments that must be administered intravenously.
Experts say the rise is partly linked to widespread antibiotic use during the COVID-19 pandemic. “We know that there was a huge surge in antibiotic use during the pandemic, so this likely is reflected in increasing drug resistance,” said Dr. Jason Burnham, a researcher at Washington University.
Antimicrobial resistance develops when bacteria and fungi evolve to withstand drugs designed to kill them. Misuse of antibiotics — such as taking unnecessary prescriptions or not completing a prescribed course — has been a key driver, making pathogens harder to treat over time.
CDC researchers analyzed data from 29 states that routinely test and report cases of carbapenem-resistant infections. In 2023, they documented 4,341 such cases, including 1,831 involving NDM. The report did not specify how many patients died.
However, the CDC stressed that the findings likely underestimate the true extent of the problem. Major states including California, Florida, New York, and Texas were not part of the dataset, and many hospitals lack the resources to conduct the genetic testing needed to detect resistance.
A separate CDC report published in June had already flagged a sharp rise in NDM cases in New York City between 2019 and 2024, reinforcing concerns about a growing national health threat.
-
Entertainment2 years agoMeta Acquires Tilda Swinton VR Doc ‘Impulse: Playing With Reality’
-
Business2 years agoSaudi Arabia’s Model for Sustainable Aviation Practices
-
Business2 years agoRecent Developments in Small Business Taxes
-
Sports2 years agoChina’s Historic Olympic Victory Sparks National Pride Amid Controversy
-
Home Improvement1 year agoEffective Drain Cleaning: A Key to a Healthy Plumbing System
-
Politics2 years agoWho was Ebrahim Raisi and his status in Iranian Politics?
-
Sports2 years agoKeely Hodgkinson Wins Britain’s First Athletics Gold at Paris Olympics in 800m
-
Business2 years agoCarrectly: Revolutionizing Car Care in Chicago
